A brief symptom index for advanced renal cell carcinoma
<p>Abstract</p> <p>Background</p> <p>Our objective was to test a brief, symptom index for advanced renal cell carcinoma, a disease affecting over 38,000 Americans each year and often diagnosed in late stages.</p> <p>Methods</p> <p>We conducted se...
Main Authors: | Cella David, Eton David T, Bacik Jennifer, Motzer Robert J |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-09-01
|
Series: | Health and Quality of Life Outcomes |
Online Access: | http://www.hqlo.com/content/4/1/68 |
Similar Items
-
Pazopanib in the treatment of advanced renal cell carcinoma
by: David Cella, et al.
Published: (2016-02-01) -
Symptom burden among patients with Renal Cell Carcinoma (RCC): content for a symptom index
by: Mahadevia Parthiv J, et al.
Published: (2007-06-01) -
Brief assessment of priority symptoms in hormone refractory prostate cancer: The FACT Advanced Prostate Symptom Index (FAPSI)
by: Banik Donald, et al.
Published: (2003-11-01) -
Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) for Lenvatinib plus Everolimus Versus Everolimus Monotherapy in Patients with Advanced Renal Cell Carcinoma
by: Chung-Han Lee, et al.
Published: (2021-09-01) -
The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)
by: Brian I. Rini, et al.
Published: (2019-12-01)